Key facts
- Notable investors include Peak Valley Capital, Sichuan Hezhong Yaoyigou Pharmaceutical.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for KidneySight Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for KidneySight Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About KidneySight Technology
Manufacturer of chronic kidney-care management monitoring devices intended to help patients with diabetic kidney disease (DKD) monitor and manage their health. The company offers continuous glucose monitoring devices, a patient app for self-reporting vital data, and a dedicated medical team for remote consultations, enabling DKD patients to receive tailored health assessments and care support.
- Sector
- Healthcare
- HQ
- Chongqing, China
- Founded
- 2020
- Website
- 591cdm.com/
- Ownership
- Privately Held (backing)
KidneySight Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in KidneySight Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on KidneySight Technology in its N-PORT filings yet. We sweep new filings monthly.